Iterion Therapeutics

Developer of therapeutics for the treatment of cancer

placeHouston, Texas, United States calendar_todayFounded 2010 groups10 employees language iteriontherapeutics.com

Innovation

7 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 142 times.

YearFilings
20181
20191
20201
20213
20223
20235
20244
20256
20262

Social engagement

Social engagement: 2.8K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Sante Ventures, Lumira Ventures.

Investor typeCountShare
Venture capital964%
Private equity17%
Angel & family office17%
Accelerator & incubator17%
Other / undisclosed214%

Recent activity

1 Jun 2026
Milestone
regulatory
13 Apr 2026
Event
AACR Annual Meeting 2026
6 Nov 2025
Event
14th Annual Texas Life Science Forum
Coming soon